Inventor · disambiguated record
Dai Cheng
Also filed as: CHENG DAI
11 granted patents·14 pending applications·68 citations·filing 2004–2024
89Inventor score
Files withCHENG DAI6ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD3Allorion Therapeutics Inc3IRM LLC3BURSULAYA BADRY2
Top patents by PatentIndex Score
25 records- 0189US8546396B2N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulatorsCHENG DAI·Filed 2010·Granted Oct 1, 2013·14 cites·18 claims
- 0286US8507491B2Compounds and compositions as hedgehog pathway inhibitorsCHENG DAI·Filed 2009·Granted Aug 13, 2013·11 cites·18 claims
- 0383US10251893B2N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulatorsNOVARTIS AG·Filed 2017·Granted Apr 9, 2019·3 cites·12 claims
- 0483US8178563B2Compounds and compositions as hedgehog pathway modulatorsGAO WENQI·Filed 2007·Granted May 15, 2012·12 cites·12 claims
- 0582US9238646B2N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as WNT signaling modulatorsCHENG DAI·Filed 2013·Granted Jan 19, 2016·5 cites·7 claims
- 0682US9181235B2Substituted pyridines for modulating the WNT signaling pathwayCHENG DAI·Filed 2011·Granted Nov 10, 2015·10 cites·15 claims
- 0780US7928133B2Compounds and compositions as hedgehog signaling pathway modulatorsIRM LLC·Filed 2007·Granted Apr 19, 2011·5 cites·6 claims
- 0876US2025002480A1Aminoheteroaryl kinase inhibitorsAllorion Therapeutics Inc·Filed 2024·Application pending·0 cites
- 0975US9216964B2Hedgehog pathway modulatorsCHENG DAI·Filed 2013·Granted Dec 22, 2015·3 cites·18 claims
- 1075US8101608B2Compounds and compositions as protein kinase inhibitorsWAN YONGQIN·Filed 2005·Granted Jan 24, 2012·5 cites·10 claims
- 1168US11384066B1Heterocyclic compounds useful as aurora a selective inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Jul 12, 2022·0 cites·4 claims
- 1264US2024166635A1Aminoheteroaryl kinase inhibitorsANRUI BIOMEDICAL TECH GUANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1364US2025320185A1Aminoheteroaryl kinase inhibitorsAllorion Therapeutics Inc·Filed 2024·Application pending·0 cites
- 1461US2025026763A1Egfr inhibitors and methods of use thereofAllorion Therapeutics Inc·Filed 2024·Application pending·0 cites
- 1558US2023128198A1Novel heterocyclic compounds useful as aurora a selective inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1655US2024246944A1Amino heteroaryl compounds and compositionsANRUI BIOMEDICAL TECH GUANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1752US8178526B2Compounds and compositions as ITPKb inhibitorsBURSULAYA BADRY·Filed 2008·Granted May 15, 2012·0 cites·7 claims
- 1852US2005124637A1Compounds and compositions as inhibitors of receptor tyrosine kinase activityIRM LLC·Filed 2004·Application pending·0 cites
- 1951US2016082014A1N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulatorsCHENG DAI·Filed 2015·Application pending·0 cites
- 2050US2024335443A1Imidazolopyridazine or pyrazolopyrimidine compounds and compositionsANRUI BIOMEDICAL TECH GUANGZHOU CO LTD·Filed 2022·Application pending·0 cites
- 2147US2010056494A1Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseasesIRM LLC·Filed 2008·Application pending·0 cites
- 2244US2011092491A1Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase ActivityNOVARTIS AG·Filed 2010·Application pending·0 cites
- 2343US2012196849A1Compounds and compositions as hedgehog pathway modulatorsGAO WENQI·Filed 2012·Application pending·0 cites
- 2441US2012202782A1Compounds and compositions as itpkb inhibitorsBURSULAYA BADRY·Filed 2012·Application pending·0 cites
- 2540US2009306039A1Compounds and compositions as itpkb inhibitorsPAN SHIFENG·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dai Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →